Deschloroketamine: Difference between revisions
>Vorpal m DXE -> DCK |
>Vorpal DXE -> DCK |
||
Line 109: | Line 109: | ||
As with other NMDA receptor antagonists, the chronic use of DCK can be considered [[Addiction potential::moderately addictive with a high potential for abuse]] and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and [[withdrawal effects]] may occur if a person suddenly stops their usage. | As with other NMDA receptor antagonists, the chronic use of DCK can be considered [[Addiction potential::moderately addictive with a high potential for abuse]] and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and [[withdrawal effects]] may occur if a person suddenly stops their usage. | ||
Tolerance to many of the effects of DCK [[Time to full tolerance::develops with prolonged and repeated use]]. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about [[Time to half tolerance::3 - 7 days]] for the tolerance to be reduced to half and [[Time to zero tolerance::1 - 2 weeks]] to be back at baseline (in the absence of further consumption). DCK presents cross-tolerance with [[Cross-tolerance::all [[dissociative]]s]], meaning that after the consumption of | Tolerance to many of the effects of DCK [[Time to full tolerance::develops with prolonged and repeated use]]. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about [[Time to half tolerance::3 - 7 days]] for the tolerance to be reduced to half and [[Time to zero tolerance::1 - 2 weeks]] to be back at baseline (in the absence of further consumption). DCK presents cross-tolerance with [[Cross-tolerance::all [[dissociative]]s]], meaning that after the consumption of DCK all [[dissociative]]s will have a reduced effect. | ||
===Urinary tract effects=== | ===Urinary tract effects=== |